VivoSeq
Other

Vitrectomy

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Vitrectomy is an early-stage landscape with 0 programs across 1 company. The most active players are AbbVie.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

92/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AbbVie logo

AbbVie

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed11 · 61%
Unknown status5 · 28%
Recruiting1 · 6%
Terminated1 · 6%

Clinical Trials

Trial Activity

18 trials

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
Recruiting·JJaeb Center for Health Research·Phase 3·NCT06790784·426 enrolled
The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV)
Completed·TThromboGenics·Phase 2·NCT01159665·38 enrolled
NSAIDs and PGE2 Levels in Vitrectomy Patients
Completed·UUniversità degli Studi di Brescia·Phase 3·NCT02361645·70 enrolled
A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.
Completed·KKing's College Hospital NHS Trust·N/A·NCT02174211·59 enrolled
Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy
Completed·AbbVie logoAbbVie·Phase 1·NCT01229410·24 enrolled
Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy
Completed·—·N/A·NCT01257698·21 enrolled
The Influence of Silicone Oil on Nerve Fiber Layer Thickness After Pars Plana Vitrectomy
Completed·UUniversity Hospital Sestre Milosrdnice·N/A·NCT01255306·60 enrolled
The Post-Vitrectomy Lenstatin™ Study
Completed·LLenstatin LLC·N/A·NCT02131194·20 enrolled
Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy
Completed·TThromboGenics·Phase 2·NCT00123279·60 enrolled
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
Completed·JJaeb Center for Health Research·Phase 2/3·NCT02858076·205 enrolled
Intravitreal Conbercept After Vitrectomy
Completed·TTianjin Medical University Eye Hospital·Phase 1·NCT03426540·50 enrolled
Triamcinolone Assisted Anterior Vitrectomy
Completed·—·Phase 2·NCT01051648·10 enrolled
SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy
Terminated·JJohns Hopkins University·Phase 1·NCT00936520·30 enrolled
The Role of Umbilical Cord Serum Therapy on Improvement of Corneal Epithelial Defect Following Diabetic Vitrectomy
Unknown status·SShahid Beheshti University of Medical Sciences·Phase 1·NCT01168375
Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
Unknown status·—·Phase 4·NCT05514925·60 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)